UiPath Inc. (NYSE:PATH) Receives Average Recommendation of "Moderate Buy" from Analysts

UiPath Inc. (NYSE:PATH - Get Free Report) has earned an average rating of "Moderate Buy" from the eighteen research firms that are currently covering the stock, Marketbeat reports. Nine equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $27.41.

A number of equities research analysts have weighed in on the stock. Mizuho upped their price target on shares of UiPath from $22.00 to $25.00 and gave the company a "neutral" rating in a report on Thursday, March 14th. Evercore ISI upped their price target on shares of UiPath from $24.00 to $27.00 and gave the company an "in-line" rating in a report on Thursday, March 14th. Royal Bank of Canada reissued a "sector perform" rating and issued a $29.00 price target on shares of UiPath in a report on Monday, April 1st. Barclays upped their price target on shares of UiPath from $23.00 to $25.00 and gave the company an "equal weight" rating in a report on Friday, March 15th. Finally, Bank of America boosted their price objective on UiPath from $26.00 to $30.00 and gave the stock a "buy" rating in a report on Thursday, March 14th.

Insiders Place Their Bets

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the company's stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $22.47, for a total transaction of $359,520.00. Following the completion of the sale, the chief financial officer now owns 103,505 shares of the company's stock, valued at $2,325,757.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 72,000 shares of company stock valued at $1,591,360 over the last 90 days. 31.03% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UiPath

Several hedge funds have recently modified their holdings of the business. Royal London Asset Management Ltd. lifted its position in UiPath by 5.9% in the third quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company's stock worth $2,388,000 after purchasing an additional 7,742 shares during the period. Barclays PLC raised its stake in UiPath by 55.2% during the second quarter. Barclays PLC now owns 968,036 shares of the healthcare company's stock worth $16,039,000 after acquiring an additional 344,499 shares in the last quarter. O Shaughnessy Asset Management LLC acquired a new position in UiPath during the third quarter worth $203,000. Invesco Ltd. raised its stake in UiPath by 2.8% during the third quarter. Invesco Ltd. now owns 399,181 shares of the healthcare company's stock worth $6,830,000 after acquiring an additional 10,863 shares in the last quarter. Finally, Symmetry Partners LLC acquired a new stake in shares of UiPath in the fourth quarter valued at $205,000. 62.50% of the stock is owned by institutional investors.

UiPath Stock Performance

Shares of UiPath stock traded up $0.15 during trading on Tuesday, hitting $21.80. 5,856,769 shares of the stock were exchanged, compared to its average volume of 9,218,472. The stock's fifty day moving average is $23.46 and its 200 day moving average is $21.29. The stock has a market cap of $12.40 billion, a PE ratio of -128.24 and a beta of 0.96. UiPath has a 12 month low of $12.38 and a 12 month high of $27.87.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.10. The business had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. Sell-side analysts anticipate that UiPath will post -0.04 EPS for the current fiscal year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.